Kevin Harper

Title: Kevin Harper: Innovator in Immunogenic Compositions

Introduction

Kevin Harper is a notable inventor based in Cheltenham, CA. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 2 patents, Harper's work focuses on enhancing vaccine efficacy and immune response.

Latest Patents

Harper's latest patents include "Immunogenic compositions and related methods" and "Antigen-adjuvant compositions and methods." The first patent discloses adjuvants for use in immunogenic compositions that comprise at least one antigen and an aluminum compound treated with various compounds. This innovation aims to provide methods for preventing and treating diseases. The second patent details vitreous compositions of an antigen and adjuvant, along with methods for creating these compositions. It also covers pharmaceutically acceptable formulations, vaccine compositions, and devices for administering these compositions to mammals.

Career Highlights

Kevin Harper is currently employed at Sanofi Pasteur Inc., where he continues to advance his research in immunogenic compositions. His work is pivotal in developing new methods for eliciting immune responses, which can lead to improved vaccine formulations.

Collaborations

Harper collaborates with talented coworkers, including Sandrine Cigarini and Manvi Hasija, who contribute to his research efforts and innovations.

Conclusion

Kevin Harper's contributions to immunology through his patents and work at Sanofi Pasteur Inc. highlight his role as an influential inventor in the field. His innovative approaches to vaccine development are paving the way for advancements in disease prevention and treatment.